Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01350544 · ClinicalTrials.gov registry record · NA

Treatment Advocacy Intervention for HIV-Positive African Americans

A NA study of HIV, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
216
Enrollment target
1
Study location

NCT01350544 is a NA study of HIV that has completed, run by Boston Children's Hospital. The registered enrollment target is 216 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01350544, a NA study of HIV, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
216 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that participants in the treatment advocacy intervention will show significantly better HIV treatment adherence than will participants in the no-treatment (wait-list) control group.

Conditions Studied

Interventions

  • BEHAVIORAL Treatment Advocacy

Study Locations (1)

California

  • AIDS Project Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2013-04
Est. Completion 2015-12
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT01350544

The ClinicalTrials.gov registry entry for NCT01350544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (51% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Treatment Advocacy is the first listed.

NCT01350544 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01350544 about?

NCT01350544 is a clinical study titled "Treatment Advocacy Intervention for HIV-Positive African Americans". The investigators hypothesize that participants in the treatment advocacy intervention will show significantly better HIV treatment adherence than will participants in the no-treatment (wait-list) control group.

What is the current status of trial NCT01350544?

This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2013-04. Estimated completion is 2015-12.

What conditions does trial NCT01350544 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT01350544?

The interventions under investigation include: Treatment Advocacy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01350544?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01350544 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.